Related Experiment Video

Updated: Jan 4, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.1K

Regionalization of congenital heart disease care: A pending goal

Juan Calderón-Colmenero1

  • 1Department of Pediatric Cardiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.

Archivos De Cardiologia De Mexico
|November 9, 2019
PubMed

Insights

Congenital heart diseases (CHDs) are a major health concern in Mexico, affecting thousands of newborns annually. Regionalizing care and fostering collaboration are crucial for improving outcomes and ensuring quality treatment for all children with CHDs.

Area of Science:

  • Public Health
  • Health Policy
  • Pediatrics

Background:

  • Congenital heart diseases (CHDs) are the most common congenital malformations.
  • In Mexico, 12,000-16,000 children are born with CHDs yearly.
  • CHDs are the second leading cause of mortality in children under 4 years old in Mexico.

Purpose of the Study:

  • To analyze the care of CHDs from a health policy perspective in Mexico.
  • To emphasize regionalizing CHD care to optimize resource utilization.
  • To improve clinical results and achieve universal, quality care for children with CHDs.

Main Methods:

  • Analysis of health policies related to CHD care in Mexico.
  • Focus on strategies for regionalizing healthcare services.
  • Emphasis on promoting inter-organizational cooperation.

Main Results:

  • Regionalization of care can rationalize resource use for CHDs.
  • Collaboration among organizations can lead to consensus and joint projects.
  • Improved resource management can enhance patient outcomes.

Conclusions:

  • Regionalizing CHD care is essential for efficient resource allocation in Mexico.
  • Inter-sectoral collaboration is vital for achieving universal and high-quality care for pediatric CHDs.
  • Policy interventions should focus on creating a coordinated network for CHD management nationwide.

Keywords:
Cardiopatías congénitasCateterismo intervencionistaChild mortalityCirugía cardíacaCongenital heart diseaseHealth policiesHeart surgeryInterventional catheterizationMexicoMortalidad infantilMéxicoPolíticas de salud

More Related Videos

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.1K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.2K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
294
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
206
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
253
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
199
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
335
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
233